Fifth-generation (5G) has gained much importance, development and investment in recent years. This technology has the potential to transform all the components of healthcare, which is especially important as the COVID-19 pandemic has put unparalleled stress on healthcare systems around the world.
Network providers and healthcare institutions are figuring out how best to incorporate this technology into the ecosystem. A new private 5G network from AT&T is helping to revolutionise the way patients and researchers connect at the Lawrence J. Ellison Institute for Transformative Medicine of USC, USA. The on-site 5G network is providing ultra-fast connectivity for patient-centred cancer research, treatment, and wellness education. The Ellison Institute is among the first medical facilities in the USA using 5G to help advance cancer research.
South Korea’s KT Corporation and the Samsung Medical Center (SMC) are working to build a smart hospital. They have jointly developed an innovative, 5G-powered medical service as an initial step to establishing a 5G smart hospital.
Sharing his thoughts, Joe Drygas, AT&T VP of Healthcare Industry Solutions, USA said, “5G has the potential to offer massive connection power, fast speeds and low latency that can help transform how healthcare is delivered. Think remote robotic surgery and quick downloads and transference of massive data files of medical imagery. 5G not only has the capacity to impact the Internet of Medical Things, but it also will help enable medical innovations using augmented reality, virtual reality, artificial intelligence, remote medical learning, remote patient monitoring, and more. Healthcare providers will be able to build an entire ecosystem that creates highly responsive, effective, patient-centric experiences”.
Upgraded Telehealth
Denne historien er fra BioSpectrum Asia August 2021-utgaven av BioSpectrum Asia.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra BioSpectrum Asia August 2021-utgaven av BioSpectrum Asia.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.
Singapore designs novel gene therapy offering hope for epilepsy patients
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.
Spider venom heart drug moves to clinical trials in Australia
A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).
India develops portable ultrasound scanner for sports injury diagnosis
A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.
Integris appoints medtech veteran Probir Das as new CEO
Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.
Clarity Pharma promotes Michelle Parker to CEO
Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.
